STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2633 by analyst upside · 2026-08-14
VTRS
Viatris Inc.
Healthcare · Market Cap $18B · P/E 0x
ANALYST PRICE TARGET
+15.3%
implied upside to consensus target
Current Price $16.04
Consensus Target $18.5
Bull Target $23.0
Bear Target $12.0
Analysts Covering 8
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
3
Hold
3
Sell
1
52-Week Low $9.43
52-Week High $18.39
YTD Return +30.8%
FUNDAMENTALS
Market Cap $18B
P/E Ratio (TTM) N/A
Forward P/E 6.0x
EPS (TTM) $-0.37
PEG Ratio 1.05
Dividend Yield 2.95%
Revenue (TTM) $14.7B
Profit Margin -2.8%
52-WEEK RANGE
52-Week Low $9.43
52-Week High $18.39
Current Price $16.04
Bear Target $12.0
Bull Target $23.0
● Now $16.04 ● Target $18.5
TRADING DATA
Avg Volume 10.2M
YTD Return +30.8%
Analyst Count 8
Consensus Buy
Upside to Target +15.3%
Last Updated 2026-08-14

ANALYST SUMMARY

Viatris Inc. (VTRS) is currently trading at $16.04 with a Wall Street consensus price target of $18.5, implying potential upside of 15.3% over the next 12 months. 8 analysts currently cover VTRS, with a consensus rating of Buy - 50% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $23.0, while the most cautious has a target of $12.0.

VTRS operates in the Healthcare sector with a market capitalisation of $18B. The stock is up 30.8% year-to-date and is currently trading near the upper end of its 52-week range of $9.43 – $18.39.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for VTRS, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Barclays - Reiterated
Overweight → Overweight 2026-05-19 Building track record
JP Morgan - Reiterated
Neutral → Neutral 2026-05-08 43% win rate (7 calls)
Truist Securities - Reiterated
Buy → Buy 2026-05-08 Building track record
Barclays - Reiterated
Overweight → Overweight 2026-03-24 Building track record
Piper Sandler - Reiterated
Neutral → Neutral 2026-01-28 14% win rate (7 calls)
Argus Research ↑ Upgrade
Hold → Buy 2026-01-16 Building track record
Barclays ● Initiated
Overweight 2025-12-09 Building track record
Truist Securities ● Initiated
Buy 2025-10-15 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
40
out of 100
Coverage depth
17/30
Consensus clarity
16/30
Vote unanimity
5/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →